Practice Guideline Update: Acute Treatment of Migraine in Children and Adolescents
Practice Guideline, August 2019
Read Published ArticleThe purpose of this guideline is to systematically assess all randomized controlled trials (RCTs) that evaluated acute migraine treatments in children and adolescents. The guideline seeks to answer the following clinical question: In children and adolescents with migraine, do acute self-administered treatments, compared with placebo, reduce headache pain and associated symptoms (nausea, vomiting, photophobia, and phonophobia) and maintain headache freedom?
Reaffirmed on October 22, 2022.
Endorsed by the American Academy of Pediatrics and the Child Neurology Society.
Clinician Tools and Materials
Clinician Summary
Download a PDF summary of this guideline product
Full-length Version
Download a PDF of the full guideline product, including full details of the methodology and data analysis
Educational Materials
Other resources related to this guideline
Guideline Translations
Read guidelines in alternative languages
Patient Tools and Materials
Patient Summary
Read a summary of the key messages of this guideline product for patients and care partners.
Press Release
Download the AAN press release about this guideline product